Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - tadalafil, quantity: 5 mg - tablet - excipient ingredients: titanium dioxide; poloxamer; iron oxide yellow; microcrystalline cellulose; triacetin; magnesium stearate; sodium lauryl sulfate; croscarmellose sodium; hypromellose; lactose - tadalafil-dr.reddy's is indicated for the treatment of:,? erectile dysfunction (ed) in adult males,? moderate to severe lower urinary tract symptoms (luts) associated with benign prostatic hyperplasia (bph) in adult males.

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - tadalafil, quantity: 2.5 mg - tablet - excipient ingredients: lactose; hypromellose; triacetin; croscarmellose sodium; titanium dioxide; iron oxide yellow; magnesium stearate; microcrystalline cellulose; purified talc; poloxamer; sodium lauryl sulfate - tadalafil-dr.reddy's is indicated for the treatment of:,? erectile dysfunction (ed) in adult males,? moderate to severe lower urinary tract symptoms (luts) associated with benign prostatic hyperplasia (bph) in adult males.

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - tadalafil, quantity: 10 mg - tablet - excipient ingredients: magnesium stearate; triacetin; croscarmellose sodium; titanium dioxide; microcrystalline cellulose; iron oxide yellow; poloxamer; sodium lauryl sulfate; hypromellose; lactose; purified talc - tadalafil-dr.reddy?s is indicated for the treatment of:,? erectile dysfunction (ed) in adult males.

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - carmustine, quantity: 100 mg - injection, diluent for - excipient ingredients: ethanol absolute - carmustine dr.reddy's is indicated as palliative therapy as a single agent or in established combination therapy with other approved chemotherapeutic agents in the following: 1. malignant glioma 2. multiple myeloma - in combination with prednisone. 3. hodgkin?s disease - as secondary therapy in combination with other approved drugs in patients who relapse while being treated with primary therapy, or who fail to respond to primary therapy. 4. non-hodgkin?s lymphomas - as secondary therapy in combination with other approved drugs for patients who relapse while being treated with primary therapy or who fail to respond to primary therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - bortezomib, quantity: 1 mg - injection, powder for - excipient ingredients: mannitol - bortezomib-dr.reddy?s, in combination with melphalan and prednisone is indicated for the treatment of patients with previously untreated multiple myeloma who are not candidates for high dose chemotherapy. bortezomib-dr.reddy?s, as part of combination therapy, is indicated for induction therapy prior to high dose chemotherapy with autologous stem cell rescue for patients under 65 years of age with previously untreated multiple myeloma. bortezomib-dr.reddy?s is also indicated for the treatment of multiple myeloma patients who have received at least one prior therapy, and who have progressive disease. bortezomib-dr.reddy?s in combination with rituximab, cyclophosphamide, doxorubicin and prednisone is indicated for the treatment of adult patients with previously untreated mantle cell lymphoma.

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - trientine dihydrochloride, quantity: 250 mg - capsule - excipient ingredients: titanium dioxide; magnesium stearate; purified water; gelatin; iron oxide yellow; macrogol 3350; colloidal anhydrous silica - trientine dihydrochloride capsules are indicated for the treatment of patients with wilson's disease who are intolerant of penicillamine.

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - carboprost trometamol, quantity: 332 microgram (equivalent: carboprost, qty 250 microgram) - injection, solution - excipient ingredients: trometamol; water for injections; benzyl alcohol; sodium chloride; sodium hydroxide; hydrochloric acid - carboprost dr.reddy?s is indicated for the treatment of postpartum haemorrhage due to uterine atony which has not responded to conventional methods of management.

India - English - Central Drugs Standard Control Organization

dr. morepen - 100/200;g

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

dr chet's pty ltd - piperonyl butoxide | melaleuca alternifolia oil | permethrin (25:75::cis:trans) - parasiticides - dog | bitch | castrate | puppy - flea | louse | skin conditions | bacterial skin conditions | ctenocephalides spp. | dermatoses | eczema | fungal skin conditions | ground fleas | nonspecific skin conditions | skin treatment

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

dr chet's pty ltd - melaleuca alternifolia oil - dermatological preps. - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - skin conditions | bacterial skin conditions | dermatoses | eczema | fungal skin conditions | nonspecific skin conditions | skin treatment